Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 27:49:101299.
doi: 10.1016/j.ijcha.2023.101299. eCollection 2023 Dec.

Correspondence: Authors' reply to Critical appraisal of "Goetz G, Wernly B, Wild C (2023) Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety. IJC Heart & Vasculature 45 (2023) 101189" by M. Nürnberg, F. Semrau

Claudia Wild  1 , Gregor Götz  1 , Bernhard Wernly  2
Affiliations

Correspondence: Authors' reply to Critical appraisal of "Goetz G, Wernly B, Wild C (2023) Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety. IJC Heart & Vasculature 45 (2023) 101189" by M. Nürnberg, F. Semrau

Claudia Wild et al. Int J Cardiol Heart Vasc. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. G. Goetz, B. Wernly, Wearable cardioverter-defibrillator (WCD) therapy for primary and secondary prevention of sudden cardiac arrest, Update 2022, Decision Support Document 103/ 2. Update 2022: 2022 [cited 24.10.2022], Available from: https://eprints.aihta.at/1407/.
    1. M. Nürnberg, F. Semrau, Critical appraisal of “Goetz G, Wernly B, Wild C (2023) Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety. IJC Heart & Vasculature 45 (2023) 101189”, Int. J. Cardiol. Heart Vasc. 48 (2023) 101258, Epub 20230830, doi: 10.1016/j.ijcha.2023.101258. - PMC - PubMed
    1. J.E. Olgin, M.J. Pletcher, E. Vittinghoff, J. Wranicz, R. Malik, D.P. Morin, et al., Wearable cardioverter-defibrillator after myocardial infarction, N. Engl. J. Med. 379(13) (2018) 1205–1215, doi: 10.1056/NEJMoa1800781, Epub 2018/10/04. - PMC - PubMed
    1. M. Weiss, G. Michels, F. Eberhardt, W. Fehske, S. Winter, F. Baer, et al., Anxiety, depression and quality of life in acute high risk cardiac disease patients eligible for wearable cardioverter defibrillator: Results from the prospective multicenter CRED-registry, PLoS One 14(3) (2019) e0213261, doi: 10.1371/journal.pone.0213261, Epub 2019/03/12. - PMC - PubMed
    1. Institute of Health Economics (IHE), Quality Appraisal Checklist for Case Series, 2016 [cited 01.07.2022], Available from: https://www.ihe.ca/research-programs/rmd/cssqac/cssqac-about.

LinkOut - more resources